chitosan has been researched along with rivaroxaban in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar, J; David, A; Khader, T; Mulcare, M; Tedeschi, C | 1 |
| Bai, H; He, H; Li, J; Liu, Y; Lou, C; Sun, P; Wu, H; Zhang, C; Zhang, L | 1 |
2 other study(ies) available for chitosan and rivaroxaban
| Article | Year |
|---|---|
Assessing Coagulation by Rotational Thromboelastometry (ROTEM) in Rivaroxaban-Anticoagulated Blood Using Hemostatic Agents.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Tests; Chitosan; Emergency Service, Hospital; Female; Hemorrhage; Hemostatics; Humans; Kaolin; Male; Middle Aged; Pilot Projects; Prospective Studies; Rivaroxaban; Sensitivity and Specificity; Thrombelastography | 2017 |
Delivery of rivaroxaban and chitosan rapamycin microparticle with dual antithrombosis and antiproliferation functions inhibits venous neointimal hyperplasia.
Topics: Animals; Chitosan; Hyaluronic Acid; Hyperplasia; Neointima; Rats; Rivaroxaban; Sirolimus; Tunica Intima | 2022 |